2-(chloromethyl)-4-(trifluoromethyl)pyridine – (215867-87-1)

Clibucaine, 15302-10-0, Clibucaine [INN], Clibucainum, Clibucaina, 1-Piperidinepropanamide, N-(2, 4-dichlorophenyl)-b-methyl-, N-(2, 4-dichlorophenyl)-3-piperidin-1-ylbutanamide, N-(2, 4-DICHLOROPHENYL)-3-(PIPERIDIN-1-YL)BUTANAMIDE, NB2ZOX88RR, Clibucainum [INN-Latin], Clibucaina [INN-Spanish], UNII-NB2ZOX88RR, BRN 0249881, beta-Piperidino-n-butyric acid 2, 4-dichloroanilide, 2', 4'-Dichloro-beta-methyl-1-piperidinepropionanilide, beta-Piperidino-n-buttersaeure 2, 4-dichloranilid [German], 1-Piperidinepropanamide, N-(2, 4-dichlorophenyl)-beta-methyl-, 2', 4'-Dichloro-beta-piperidinobutyranilide, beta-Piperidino-n-buttersaeure 2, 4-dichloranilid, CLIBUCAINE [WHO-DD], Oprea1_699544, SCHEMBL248923, 1-Piperidinepropionanilide, 2', 4'-dichloro-beta-methyl-, CHEMBL2104620, NIOSH/TN3707300, DTXSID80864581, EX-A4493, AKOS030228374, HY-W694291, AS-70065, DA-62391, CS-0778917, NS00100932, TN37073000, A11468, 2', 4'-DICHLORO-.BETA.-PIPERIDINOBUTYRANILIDE, Q27284770, N-(2, 4-Dichlorophenyl)-beta-methyl-1-piperidinepropionamide, 1-Piperidinepropionamide, N-(2, 4-dichlorophenyl)-beta-methyl-